Epstein Secrets

onversations will continue." Senate Majority Leader McConnell was more pessimistic about the prospects for an agreement. The Washington Post (9/30, Werner, Stein, 14.2M) reports he said the sides were "very, very far apart." The Post says his comments left it "uncertain whether any agreement struck by

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

onversations will continue." Senate Majority Leader McConnell was more pessimistic about the prospects for an agreement. The Washington Post (9/30, Werner, Stein, 14.2M) reports he said the sides were "very, very far apart." The Post says his comments left it "uncertain whether any agreement struck by

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

onversations will continue." Senate Majority Leader McConnell was more pessimistic about the prospects for an agreement. The Washington Post (9/30, Werner, Stein, 14.2M) reports he said the sides were "very, very far apart." The Post says his comments left it "uncertain whether any agreement struck by

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v